abstract |
The present invention concerns novel compounds of formula <CHEM> the N-oxide forms, the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein L represent a radical of formula <CHEM> wherein each Alk independently represents an optionally substituted C1-6alkanediyl; n is 1, 2 or 3; Y is O, S or NR<2>; R<1> represents hydrogen, aryl, Het<1>, or an optionally substituted C1-6alkyl; each R<2> independently represents hydrogen or C1-6alkyl; or in case R<1> and R<2> are attached to the same nitrogen atom, they may be taken together to form a heterocyclic radical; or they may be taken together to form an azido radical; each R<3> independently represents hydrogen, hydroxy or C1-4alkyloxy; aryl represents phenyl, naphthalenyl, 1,2,3,4-tetrahydro-naphthalenyl, indenyl or indanyl; each of said aryl groups may optionally be substituted; Het<1> represents an optionally substituted monocyclic or bicyclic heterocyclic radical; Het<2> is the same as Het<1> and may also be piperazinyl, homopiperazinyl, 1,4-dioxanyl, morpholinyl, thiomorpholinyl; R<6> represents hydrogen or C1-4alkyl; R<7> represents hydrogen or C1-4alkyl; or R<6> and R<7> taken together form a bivalent radical of formula -N=CH- (i), -CH=N- (ii), -CH=CH-(iii), wherein one hydrogen atom in the radicals (i) and (ii) may be optionally be replaced and up to two hydrogen atoms in radical (iii) may optionally be replaced; D represents a trisubstituted (1,3-dioxolane or tetrahydrofuran) derivative; as antifungals; their processes for preparation, compositions containing them and their use as a medicine. |